KH

Kouki Harasaki

Bioluminescence Ventures

San Francisco, California

Investor
VC
Operator

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $2,000,000.00

  • Max Investment:

    $10,000,000.00

  • Target Investment:

    $6,000,000.00

Skills

Biotechnology
Protein Chemistry
Molecular Biology
Assay Development
Oncology
Licensing Negotiations
Due Diligence
Financial Modeling
Biochemistry
RNAi
Business Development
Venture Capital
Animal Pharmacology
Tissue Culture
Cell Biology
Drug Development
Clinical Research
Corporate Development
Strategy
Emerging Markets

Education

Investments

Cerevance

Series B

Total Funding: $160M

ReCode Therapeutics

Series B

Total Funding: $210M

SURGE Therapeutics

Series B

Total Funding: $58M

Ensoma

Series B

Total Funding: $210M

Nido Biosciences

Series B

Total Funding: $87M

Karlsgate

Seed

Total Funding: $4M

Artificial

Series A

Total Funding: $22M

Work Experience

Bioluminescence Ventures

2022

  • Founding & Managing Partner

    2022

Cerevance

2024

  • Board Director

    2024

    Finance Committee Member

ReCode Therapeutics

2023

  • Board Director

    2023

    Nominating & Corporate Governance Committee Member Transaction Committee Member

SURGE Therapeutics

2023

  • Board Director

    2023

Ensoma

2023

  • Board Director

    2023

    Compensation Committee Member

Nido Biosciences

2023

  • Board Director

    2023

    Compensation Committee Member Audit Committee Member

M12 - Microsoft's Venture Fund

2020 - 2022

  • Managing Director / Biotechnology Lead Investor

    2020 - 2022

1910 Genetics

2021 - 2022

  • Board Director

    2021 - 2022

Artificial, Inc.

2021 - 2022

  • Board Director

    2021 - 2022

Huue

2021 - 2022

  • Board Observer

    2021 - 2022